Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Volume Plasma Exchange in Acute Liver Failure
NCT02718079Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Dec 2016
- Primary completion
- Oct 2018
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Survival at 21 days. Started Dec 2016; status: completed.
Beyond the preview
Go deeper on NCT02718079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02718079.